Research ExplorerScientific StaffJulia Hambach Publications

Julia Hambach

graph of relations
Affiliations
1 - 13 out of 13Page size: 50

Publications

  1. 2024

  2. An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells

    Seifert, L., Riecken, K., Zahner, G., Hambach, J., Hagenstein, J., Dubberke, G., Huber, T. B., Koch-Nolte, F., Fehse, B. & Tomas, N. M., 04.2024, In: KIDNEY INT. 105, 4, p. 886-889 4 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  3. Generation and characterization of antagonistic anti-human CD39 nanobodies

    Menzel, S., Duan, Y., Hambach, J., Albrecht, B., Wendt-Cousin, D., Winzer, R., Tolosa, E., Rissiek, A., Guse, A. H., Haag, F., Magnus, T., Koch-Nolte, F. & Rissiek, B., 2024, In: FRONT IMMUNOL. 15, p. 1328306

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2022

  5. High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1

    Kuzikov, M., Woens, J., Zaliani, A., Hambach, J., Eden, T., Fehse, B., Ellinger, B. & Riecken, K., 07.2022, In: BIOMED PHARMACOTHER. 151, 113104.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy

    Pape, L. J., Hambach, J., Gebhardt, A. J., Rissiek, B., Stähler, T., Tode, N., Khan, C., Weisel, K., Adam, G., Koch-Nolte, F. & Bannas, P., 2022, In: FRONT IMMUNOL. 13, 1010270.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

    Hambach, J., Fumey, W., Stähler, T., Gebhardt, A. J., Adam, G., Weisel, K., Koch-Nolte, F. & Bannas, P., 2022, In: FRONT IMMUNOL. 13, 838406.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors

    Hambach, J., Mann, A. M., Bannas, P. & Koch-Nolte, F., 2022, In: FRONT IMMUNOL. 13, 1005800.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  9. 2021

  10. A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein

    Hambach, J., Stähler, T., Eden, T., Wendt, D., Tode, N., Haag, F., Tolosa, E., Altfeld, M., Fathi, A., Dahlke, C., Addo, M. M., Menzel, S. & Koch-Nolte, F., 09.2021, In: IMMUN INFLAMM DIS. 9, 3, p. 905-917 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells

    Baum, N., Fliegert, R., Bauche, A., Hambach, J., Menzel, S., Haag, F., Bannas, P. & Koch-Nolte, F., 01.2021, In: CANCERS. 13, 1

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells

    Baum, N., Eggers, M., Koenigsdorf, J., Menzel, S., Hambach, J., Staehler, T., Fliegert, R., Kulow, F., Adam, G., Haag, F., Bannas, P. & Koch-Nolte, F., 2021, In: FRONT IMMUNOL. 12, 703574.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2020

  14. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)

    Hambach, J., Riecken, K., Cichutek, S., Schütze, K., Albrecht, B., Petry, K., Röckendorf, J. L., Baum, N., Kröger, N., Hansen, T., Schuch, G., Haag, F., Adam, G., Fehse, B., Bannas, P. & Koch-Nolte, F., 29.01.2020, In: CELLS-BASEL. 9, 2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies

    Schriewer, L., Schütze, K., Petry, K., Hambach, J., Fumey, W., Koenigsdorf, J., Baum, N., Menzel, S., Rissiek, B., Riecken, K., Fehse, B., Röckendorf, J. L., Schmid, J., Albrecht, B., Pinnschmidt, H., Ayuk, F., Kröger, N., Binder, M., Schuch, G., Hansen, T., Haag, F., Adam, G., Koch-Nolte, F. & Bannas, P., 2020, In: THERANOSTICS. 10, 6, p. 2645-2658 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. 2018

  17. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

    Schütze, K., Petry, K., Hambach, J., Schuster, N., Fumey, W., Schriewer, L., Rockendorf, J., Menzel, S., Albrecht, B., Haag, F., Stortelers, C., Bannas, P. & Koch-Nolte, F., 19.11.2018, In: FRONT IMMUNOL. 9, p. 2553

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2017

  19. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics

    Bannas, P., Hambach, J. & Koch-Nolte, F., 2017, In: FRONT IMMUNOL. 8, p. 1603

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research